HRT Financial’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-351,489
Closed -$2.94M – 5165
2026
Q1
$2.94M Buy
351,489
+51,574
+17% +$542K 0.01% 1331
2025
Q4
$4.32M Buy
299,915
+127,729
+74% +$1.59M 0.01% 850
2025
Q3
$1.66M Buy
+172,186
New +$1.52M 0.01% 1253
2025
Q2
– Sell
-183,424
Closed -$1.31M – 3392
2025
Q1
$1.31M Sell
183,424
-179,979
-50% -$1.34M 0.01% 1003
2024
Q4
$2.81M Buy
363,403
+129,404
+55% +$1.21M 0.01% 610
2024
Q3
$2.45M Buy
+233,999
New +$2.85M 0.01% 801
2024
Q1
– Sell
-15,828
Closed -$284K – 2963
2023
Q4
$284K Buy
+15,828
New +$279K ﹤0.01% 1649
2023
Q3
– Sell
-18,939
Closed -$378K – 2979
2023
Q2
$378K Buy
+18,939
New +$365K ﹤0.01% 1491
2023
Q1
– Sell
-44,462
Closed -$1.01M – 3081
2022
Q4
$1.01M Buy
44,462
+36,711
+474% +$830K 0.01% 960
2022
Q3
$204K Buy
+7,751
New +$230K ﹤0.01% 2202
2021
Q1
– Sell
-6,895
Closed -$312K – 3075
2020
Q4
$312K Sell
6,895
-25,514
-79% -$892K 0.01% 1267
2020
Q3
$891K Buy
+32,409
New +$1.06M 0.03% 614
2020
Q1
– Sell
-8,317
Closed -$340K – 1256
2019
Q4
$340K Buy
+8,317
New +$329K 0.01% 693

Other funds holding RGNX

HRT Financial's RGNX Position: Q2 2026 in Review

HRT Financial sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 351,489 shares — an estimated $2.94M sold.

HRT Financial first reported a position in RGNX in Q4 2019 and held it in 13 quarters. The position peaked at $4.32M in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • HRT Financial reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 351,489 Regenxbio shares in Q2 2026, an estimated $2.94M.
  • HRT Financial first reported a position in Regenxbio in Q4 2019 and held it in 13 quarters.
  • HRT Financial's Regenxbio position peaked at $4.32M in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.